Table 1.
Sample characteristics N = 421
| Characteristics | Frequency n (%) |
|---|---|
| Demographics | |
| Gender | |
| Female | 266 (63.2) |
| Beyond primary education | 166 (39.4) |
| Marital status | |
| Married | 189 (44.9) |
| Separated/Divorced | 68 (16.2) |
| Widowed | 144 (34.2) |
| Never married | 20 (4.8) |
| Religion | |
| Protestant | 226 (53.7) |
| Catholic | 134 (31.8) |
| Muslim | 38 (9.0) |
| WHO stage of disease | |
| I | 17 (4) |
| II | 56 (13.3) |
| III | 197 (46.8) |
| IV | 64 (15.2) |
| Individual antiretrovirals | |
| NRTIs | |
| Zidovudine | 43 (21.4) |
| Stavudine | 158 (78.6) |
| Lamivudine | 188 (93.5) |
| Abacavir | 1 (0.5) |
| Didanosine | 1 (0.5) |
| NNRTIs | |
| Nevirapine | 163 (81.1) |
| Efavirenz | 38 (18.9) |
| PIs | |
| Lopinavir/ritonavir | 1 (0.5) |
Abbreviations: NRTIs = nucleoside reverse transcriptase inhibitors, NNRTIs = non-nucleoside reverse transcriptase inhibitors, PIs = protease inhibitors